Founded in 1993, Suanfarma is a B2B partner in the life sciences sector, committed to health and innovation through the sustainable development, manufacturing, and distribution of high-quality pharmaceutical ingredients.

Through its Suanfarma CDMO division, the company offers advanced capabilities in fermentation and chemical synthesis projects, acting as a one-stop shop for the development, scale-up, manufacturing, and commercialization of both innovative and generic APIs. All facilities comply with the highest industry standards and regulations.

With a global network of 12 local offices and presence in more than 70 countries, Suanfarma serves over 400 international clients.
Since 2021, Suanfarma has been part of the Archimed ecosystem, a private equity firm specialized in the healthcare sector that supports the company’s growth and global strategy through its expertise and resources.